IL-17A/F drugs for Hidradenitis Suppurativa

3 tracked IL-17A/F drugs in the Hidradenitis Suppurativa race. The class explanation lives on the IL-17A/F page; the full indication pipeline across every mechanism is on the Hidradenitis Suppurativa page.

1 approved / phase 41 Phase 31 Phase 2

Head-to-head evidence: bimekizumab vs ORKA-002 · bimekizumab vs sonelokimab

The roster

← all IL-17A/F drugs